Fan Fan
Fortuna: 159 M $ al 31/05/2026
Fortuna: 159 M $ al 31/05/2026
Fan Fan is currently Vice Chairman at Chengdu.
Olymvax.
Biopharmaceuticals, Inc. since 2022, with employment at the firm starting in 2010.
Education history includes a doctorate from Southwest University of Political & Law, an undergraduate degree from Manchester Metropolitan University, and a graduate degree from Imperial College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 30.509.220 ( 7,53 % ) | 158 M $ | 31/05/2026 | |
| 31/03/2026 | 36.800 ( -.--% ) | 191 108 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CHENGDU OLYMVAX BIOPHARMACEUTICALS INC. | Director/Miembro de la Junta | 12/01/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Manchester Metropolitan University
Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southwest University of Political & Law
Southwest University of Political & Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chengdu Olymvax Biopharmaceuticals, Inc.
Chengdu Olymvax Biopharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in research and development, manufacturing & sale of vaccine products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.